A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients

Completed · Phase 3

Conditions studied: Kidney Transplantation

In brief

This study will compare kidney function in kidney transplant patients following treatment with various combinations of Zenapax, CellCept, corticosteroids, and Neoral (Cyclosporine). The anticipated time on study treatment is 6-12 months, and the target sample size is 500+ individuals.

Key facts

Study ID

NCT00048152

Run by

Hoffmann-La Roche

People needed

539

Starts

2000-12-01

Expected to finish

2006-03-01

Last updated by the study team

2016-11-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• adult patients greater than 18 years of age
• recipients of primary kidney transplant
• single-organ recipients (kidney only)

You may not qualify if…

• previous treatment with Zenapax
• history of malignancy (except localized skin cancer)

Where it is running

• Study site — Birmingham, Alabama, United States
• Study site — San Francisco, California, United States
• Study site — Gainesville, Florida, United States
• Study site — Atlanta, Georgia, United States
• Study site — Livingston, New Jersey, United States
• Study site — Philadelphia, Pennsylvania, United States
• Study site — Charleston, South Carolina, United States
• Study site — Falls Church, Virginia, United States
• Study site — Adelaide, Australia
• Study site — Sydney, Australia
• Study site — Brussels, Belgium
• Study site — Leuven, Belgium
• Study site — Calgary, Alberta, Canada
• Study site — Edmonton, Alberta, Canada
• Study site — Vancouver, British Columbia, Canada
• Study site — Saskatoon, Saskatchewan, Canada
• Study site — Vandœuvre-lès-Nancy, France
• Study site — Berlin, Germany
• Study site — Hanover, Germany
• Study site — Münster, Germany
• Study site — Mexico City, Mexico
• Study site — Monterrey, Mexico
• Study site — Oslo, Norway
• Study site — Warsaw, Poland
• Study site — Wroclaw, Poland

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.